Boston Scientific Corp. artificially inflated its stock price by touting growth in key product segments that it knew was unsustainable, leading to a disappointing revenue report and a significant stock drop, an investor alleges.
Wall Street’s two top regulators are discussing plans to move into the same building complex in Washington just steps from the US Capitol, according to people familiar with the matter.
The Iran war rattled but didn’t break Wall Street this week. Instead it exposed the limits of
An unexpected hiring slump threatens to upend the prevailing view among Federal Reserve policymakers that a stabilizing labor market will allow them to keep interest rates steady as they fight persistent inflation.
Verrica Pharmaceuticals Inc. investors can proceed as a class in their suit over allegedly concealed ongoing drug production problems that delayed FDA approval, a federal court ruled.
Thinning reserves and negative cash flows will likely lead
Kalshi Inc. should’ve paid out on a $54 million market speculating when Iran’s Supreme Leader Ali Khamenei would vacate his role after he was killed during US and Israeli airstrikes, a proposed class action said.
The
Get the latest legal, regulatory, and enforcement news and analysis, as well as in-depth business and industry covering in the following areas:
